Charlie's Holdings, a U.S. electronic cigarette company, experienced a 4.6% increase in stock during midday trading in the past few days. The company's trading price reached up to $0.12, equivalent to approximately ¥0.84. The stock remained at $0.12 from the last trading price, and had previously closed at $0.11.
The 50-day moving average price of Charlie Holdings is $0.13, while its 200-day moving average price stands at $0.10.
Charlie Holdings and its subsidiaries engage in the production, manufacturing, and distribution of electronic cigarette e-liquids and vaping products in the United States and overseas. One of its subsidiaries, Pachamama, saw its disposable e-cigarette product sell out within just 21 days. The company sells its products to approximately 80 countries through distributors, specialized retailers, and third-party online dealers, with a focus on the United Kingdom, Italy, Spain, Belgium, Australia, Sweden, and Canada.
It has been reported that in 2021, Charlie Holdings Company announced that it had raised $3 million by selling 351,669,883 shares of common stock to its founder and CEO, Brandon Stump, and COO, Ryan Stump. The company intends to use the funds raised to drive significant growth in the future, facilitate the release of new products, increase operating capital, repay outstanding debt, and for other general corporate purposes.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
